IPO filing research

LumiraDx Ltd

Pharmaceutical Preparations

follow-on priced EFFECT

LumiraDx Ltd IPO research page with SEC filing history, offering status, deal terms, structured filing extracts, company news, and comparable IPO context. Latest filing: EFFECT on 2023-05-15.

Filing Timeline

SEC EDGAR

EFFECT effective

SEC effectiveness notice

SEC declared the registration statement effective, allowing the offering to proceed.

Follows 20-F and marks the registration effective.

2023-05-15 · 9999999995-23-001441

20-F supplemental

20-F

Pre-IPO filing captured from the SEC submission timeline.

Follows EFFECT in the pre-IPO sequence.

2023-05-01 · 0000950170-23-016045

EFFECT effective

SEC effectiveness notice

SEC declared the registration statement effective, allowing the offering to proceed.

Follows 424B3 and marks the registration effective.

2022-10-05 · 9999999995-22-002934

424B3 priced

Final prospectus

Final prospectus filed near launch with final deal terms.

Follows 424B3 and confirms the priced prospectus.

2022-09-29 · 0001193125-22-253499

424B3 priced

Final prospectus

Final prospectus filed near launch with final deal terms.

Follows 424B3 and confirms the priced prospectus.

2022-08-16 · 0001193125-22-221759

424B3 priced

Final prospectus

Final prospectus filed near launch with final deal terms.

Follows 424B4 and confirms the priced prospectus.

2022-07-29 · 0001193125-22-206821

424B4 priced

Final prospectus

Final prospectus filed after pricing with final deal terms.

Follows EFFECT and confirms the priced prospectus.

2022-07-21 · 0001193125-22-199269

EFFECT effective

SEC effectiveness notice

SEC declared the registration statement effective, allowing the offering to proceed.

Follows F-1 and marks the registration effective.

2022-07-20 · 9999999995-22-002118

F-1 filed

Initial foreign registration statement

Initial public filing for a foreign issuer submitted to start the SEC review process.

Follows DRS in the pre-IPO sequence.

2022-07-19 · 0001193125-22-196573

DRS filed

Draft registration statement

Draft registration filed confidentially before the public launch.

Begins the tracked draft filing sequence after 424B3.

2022-06-21 · 0000950123-22-006884

424B3 priced

Final prospectus

Final prospectus filed near launch with final deal terms.

Follows EFFECT and confirms the priced prospectus.

2022-06-07 · 0001193125-22-168597

EFFECT effective

SEC effectiveness notice

SEC declared the registration statement effective, allowing the offering to proceed.

Follows F-1/A and marks the registration effective.

2022-06-06 · 9999999995-22-001700

F-1/A amended

Amended foreign registration statement

Updated foreign registration statement filed after SEC comments or deal changes.

Updates the prior F-1 filing.

2022-05-27 · 0001193125-22-162342

F-1 filed

Initial foreign registration statement

Initial public filing for a foreign issuer submitted to start the SEC review process.

Follows 20-F in the pre-IPO sequence.

2022-05-02 · 0001193125-22-136761

20-F supplemental

20-F

Pre-IPO filing captured from the SEC submission timeline.

Follows CERT in the pre-IPO sequence.

2022-04-13 · 0000950170-22-005635

CERT inactive

CERT

Pre-IPO filing captured from the SEC submission timeline.

Follows 20-F in the pre-IPO sequence.

2021-09-29 · 0001354457-21-001091

20-F supplemental

20-F

Pre-IPO filing captured from the SEC submission timeline.

Follows 8-A12B in the pre-IPO sequence.

2021-09-29 · 0001193125-21-286178

8-A12B effective

Exchange Act registration

Registration filed to list the securities under the Exchange Act ahead of trading.

Follows 424B3 and registers the class of securities for exchange listing.

2021-09-28 · 0001193125-21-285575

424B3 priced

Final prospectus

Final prospectus filed near launch with final deal terms.

Follows EFFECT and confirms the priced prospectus.

2021-09-10 · 0001193125-21-269653

EFFECT effective

SEC effectiveness notice

SEC declared the registration statement effective, allowing the offering to proceed.

Follows 424B3 and marks the registration effective.

2021-09-03 · 9999999995-21-003411

424B3 priced

Final prospectus

Final prospectus filed near launch with final deal terms.

Follows F-4/A and confirms the priced prospectus.

2021-09-03 · 0001193125-21-265539

F-4/A amended

F-4/A

Pre-IPO filing captured from the SEC submission timeline.

Updates the prior F-4/A filing.

2021-09-01 · 0001193125-21-263298

F-4/A amended

F-4/A

Pre-IPO filing captured from the SEC submission timeline.

Updates the prior 425 filing.

2021-08-27 · 0001193125-21-259513

425 supplemental

425

Pre-IPO filing captured from the SEC submission timeline.

Follows F-4/A in the pre-IPO sequence.

2021-08-20 · 0001193125-21-252617

F-4/A amended

F-4/A

Pre-IPO filing captured from the SEC submission timeline.

Updates the prior 425 filing.

2021-08-20 · 0001193125-21-252598

425 supplemental

425

Pre-IPO filing captured from the SEC submission timeline.

Follows F-4 in the pre-IPO sequence.

2021-07-19 · 0001193125-21-217600

F-4 filed

F-4

Pre-IPO filing captured from the SEC submission timeline.

Follows DRS/A in the pre-IPO sequence.

2021-07-07 · 0001193125-21-209905

DRS/A amended

Amended draft registration statement

Updated draft registration filed before the public launch.

Updates the prior DRS filing.

2021-06-16 · 0000950123-21-007891

DRS filed

Draft registration statement

Draft registration filed confidentially before the public launch.

Begins the tracked draft filing sequence after RW.

2021-04-20 · 0000950123-21-004736

RW withdrawn

Withdrawal request

Issuer requested withdrawal of the registration statement.

Follows F-1 and ends the active registration process.

2021-04-07 · 0001193125-21-108304

F-1 filed

Initial foreign registration statement

Initial public filing for a foreign issuer submitted to start the SEC review process.

Follows DRS/A in the pre-IPO sequence.

2021-01-15 · 0001193125-21-010218

DRS/A amended

Amended draft registration statement

Updated draft registration filed before the public launch.

Updates the prior DRS/A filing.

2020-12-23 · 0000950123-20-012885

DRS/A amended

Amended draft registration statement

Updated draft registration filed before the public launch.

Updates the prior DRS/A filing.

2020-10-14 · 0000950123-20-010244

DRS/A amended

Amended draft registration statement

Updated draft registration filed before the public launch.

Updates the prior DRS filing.

2020-09-10 · 0000950123-20-009619

DRS filed

Draft registration statement

Draft registration filed confidentially before the public launch.

First tracked pre-IPO filing for this issuer.

2020-08-03 · 0000950123-20-007575

Comparable Deals

20 comparable deals

Healthcare & BiotechLast 18 months

Only 0 strict matches; expanded to 20 using nearest neighbors.

Showing top 8 by similarity.

+9.1%

Median day-1

60%

Above issue

+0.7%

Median week-1

-20.9%

Downside (p10)

BlossomHill Therapeutics, Inc. BLSM

2026-08-07 $150M Day 1: +0.0% Wk 1: +0.0%

same SICrecent IPO

Latigo Biotherapeutics, Inc. LTGO

2026-08-07 $346M Day 1: +1.4% Wk 1: +1.4%

same SICrecent IPO

Braveheart Bio, Inc. BRVE

2026-08-06 $383M Day 1: +65.6% Wk 1: +66.7%

same SICrecent IPO

Apnimed, Inc. APMD

2026-07-31 $192M Day 1: +43.6% Wk 1: +74.3%

same SICrecent IPO

Kardigan, Inc. KARD

2026-06-18 $400M Day 1: +37.5% Wk 1: +41.1%

same SICrecent IPO

Parabilis Medicines, Inc. PBLS

2026-06-10 $670M Day 1: +58.0% Wk 1: +30.2%

same SICrecent IPO

Seaport Therapeutics, Inc. SPTX

2026-05-01 $255M Day 1: +10.2% Wk 1: -13.9%

same SICrecent IPO

Avalyn Pharma Inc. AVLN

2026-04-30 $300M Day 1: +63.8% Wk 1: +53.9%

same SICrecent IPO

Recent News

No recent news stored for this issuer.